ACAAI 2018: Benralizumab Reduces Need for Rescue Medication in Uncontrolled Asthma With Eosinophilic Inflammation
Benefits are seen as early as day 3 after the first dose
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.